Catalent To Acquire Accucaps Industries Limited

Catalent Pharma Solutions has agreed to acquire Accucaps Industries Limited, the Canada-based developer and manufacturer of Over-the-Counter (OTC), high potency and conventional pharmaceutical softgels.

Athena2

The acquisition, which is subject to Canadian governmental approval, will substantially strengthen Catalent’s global softgel capabilities with the addition of a portfolio of OTC and prescription products supplied to the North American market. Accucaps’ two state-of-the-art facilities in Ontario, Canada offer integrated development, manufacturing and packaging solutions.

This acquisition strengthens Catalent’s ability to offer customers full-service, turnkey solutions and complements Catalent’s OTC and prescription development and supply expertise, as well as its overall softgel production capacity.

Read full press release here.

This acquisition comes on the heels of Catalent's recent acquisition of Pharmatek Laboratories, adding extensive early phase development and spray dry capabilities to provide a fully comprehensive portfolio of drug development and bioavailability enhancement solutions. Learn more here.

Capabilities

Catalent RP Scherer Softgel is a global leader in innovative oral and topical softgel technologies for the pharmaceutical, consumer health, and cosmetic markets. Upon completion of the acquisition, Accucaps’ two facilities in Windsor and Strathroy, Ontario, will be added to Catalent’s global network of 11 Softgel Technologies facilities. These facilities house sizeable blistering, bottling and other packaging capabilities, as well as high-potency prescription softgel development and manufacturing that is complementary to Catalent’s expertise in innovative oral and topical softgel technologies.

11_CH_Softgel_OTC_A1

  • Product Development – Focused on developing complex products encapsulated in a softgel format (oral capsules and twist-off topical capsules), high potency APIs, differentiated OTC products and products with complex bio-equivalency or clinical studies.
  • Monograph OTC Products – Wide range of OTC monograph products, with flexible options including full service commercial packaging to meet the specific needs of OTC companies.
  • Packaging Capabilities – Customized packaging solutions extending from pack development to full commercial scale packaging with modern, state-of-the-art equipment to bring value and flexibility to customers’ supply chains.  Complete packaging solutions from clinical and stability to market-ready with fully customized packaging solutions in both blister and bottle formats.
Facilities

Upon completion of the acquisition, Accucaps’ over 500 employees at its two facilities in Windsor and Strathroy, Ontario, will join Catalent’s global network of 11 softgel technologies facilities.